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Yeast metabolic chassis designs for 
diverse biotechnological products
Paula Jouhten1, Tomasz Boruta2, Sergej Andrejev1, Filipa Pereira1, Isabel Rocha3 & 
Kiran Raosaheb Patil1
The diversity of industrially important molecules for which microbial production routes have been 
experimentally demonstrated is rapidly increasing. The development of economically viable producer 
cells is, however, lagging behind, as it requires substantial engineering of the host metabolism. A 
chassis strain suitable for production of a range of molecules is therefore highly sought after but 
remains elusive. Here, we propose a genome-scale metabolic modeling approach to design chassis 
strains of Saccharomyces cerevisiae – a widely used microbial cell factory. For a group of 29 products 
covering a broad range of biochemistry and applications, we identified modular metabolic engineering 
strategies for re-routing carbon flux towards the desired product. We find distinct product families 
with shared targets forming the basis for the corresponding chassis cells. The design strategies include 
overexpression targets that group products by similarity in precursor and cofactor requirements, as 
well as gene deletion strategies for growth-product coupling that lead to non-intuitive product groups. 
Our results reveal the extent and the nature of flux re-routing necessary for producing a diverse range 
of products in a widely used cell factory and provide blueprints for constructing pre-optimized chassis 
strains.
Baker’s yeast, Saccharomyces cerevisiae, is among the most widely used cell factories, utilized in biotechnological 
processes ranging from bioethanol to insulin production. A large knowledge base and considerable expertise exist 
for this fungus in both academia and industry, making it an attractive host for producing new products. Yet, the 
development of a new production-quality strain is a time-consuming as well as resource-consuming endeavor. 
Without substantial engineering of the host metabolism, yields from heterologous production pathways tend to 
remain low and economically unattractive1–3. Diverting the input carbon flux away from ethanol, biomass and 
CO2 production, and to the desired product, requires considerable expertise and several trial-and-error cycles of 
identifying and implementing genetic engineering targets. These hurdles hamper innovation and delay realization 
of final bioprocesses. Consequently, the idea of chassis cells, which are pre-engineered for the production of a 
variety of molecules, has received considerable traction in recent years4–6.
Since various compounds of biotechnological interest originate from a limited number of metabolic pre-
cursors, a major focus in the engineering of chassis strains has been on increasing the precursors’ availability. 
Primary precursors of recent interest include acetyl-CoA, malonyl-CoA, farnesyl diphosphate and aromatic 
amino acids7–14. Malonyl-CoA acts as a precursor for a range of products, including fatty acid ethyl esters and 
3-hydroxypropionic acid. Furthermore, farnesyl diphosphate, which is derived from acetyl-CoA via the meva-
lonate pathway in native yeast metabolism, is a precursor for sterols and isoprenoids. Indeed, a strain with an 
improved farnesyl diphosphate pool has been suggested as a platform for products drawing precursors from the 
mevalonate pathway14. Aromatic amino acids and related metabolites are also precursors for many products, such 
as polyketides, vanillin and p-hydroxycinnamic acid.
In addition to increasing precursor supply, cellular redox balance has been another major target area to drive 
or enhance the production. Nissen et al.15 pioneered redox engineering in yeast by switching L-glutamate synthe-
sis from an NADPH-dependent to an NADH-dependent reaction. This decreased anaerobic glycerol secretion 
and diverted more glucose to ethanol15. Further examples of successful redox engineering in S. cerevisiae include 
NADPH-consuming isoprenoid production16,17 and NADH-generating 2,3-butanediol production18.
The strain engineering strategies towards increasing precursor and cofactor availability can be rationalized 
using genome-scale metabolic models19,20. Such models are now available for a number of industrially rele-
vant microbial hosts including S. cerevisiae. Furthermore, state-of-the-art computational methods allow rapid 
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reconstruction of new models with as little information as genome sequence21,22. Genome-scale metabolic models 
form the basis of various algorithms for designing metabolic engineering strategies. These include OptKnock23 
and its successor OptGene24, which identify gene deletion strategies to couple production flux to cell growth, 
where the main idea is that the cell’s evolution-driven biological objective ‘to grow’ would support the engineer-
ing objective of producing the compound of interest. Such growth-product coupling has been a success story in 
the field of model-guided rational design, with experimental demonstration for, among others, succinate25 and 
isoprenoid production26.
Biological objectives other than optimal growth may be relevant for designing metabolic engineering 
strategies. For example, endogenous flux regulation in non-evolved mutant strains may support production. 
Algorithms like MoMA27 and MiMBl28 have been shown to predict well the phenotypes of gene deletion mutants 
and can thus be used to identify metabolic engineering strategies. Moreover, methods have also been proposed to 
identify combinations of gene deletions and flux over-expressions to achieve high production levels29–31.
In this study, we address the design of a set of pre-optimized S. cerevisiae chassis cells. We aim at exploiting the 
modularity of cellular biochemistry from a production perspective, wherein different production pathways often 
share pre-cursors and co-factors. This, together with genome-scale metabolic models, enabled us to design mod-
ularized metabolic engineering strategies for re-routing carbon flux towards different groups of desired products.
Methods
Models for 29 products. We reconstructed biosynthetic pathways for 28 products requiring heterologous 
gene expression in S. cerevisiae based on literature data (Fig. 1, Supplementary information). In addition, succinic 
acid was used as a representative endogenous product. For simplicity and due to the unavailability of information, 
no additional energetic and precursor requirements were included for the synthesis of the heterologous enzymes 
or for the secretion of products or by-products. To represent the native metabolism of S. cerevisiae, we used the 
genome-scale metabolic model iFF70832. Among the available yeast models, iFF708 is particularly well suited for 
predicting metabolic flux phenotypes33. To further improve the model for metabolic engineering target identifi-
cation, various curation and pre-processing steps were applied, using Matlab R2015a v. 8.5.0 with Cobra Toolbox 
v. 2.0.634, as follows. Duplicated reactions were removed and the corresponding isoenzymes were included in the 
gene-reaction rules. Secretion of acetaldehyde and glucoseamine 6-phosphate were not allowed, as acetaldehyde 
is cytotoxic and is usually not secreted by yeast in large quantities35, and phosphorylated compounds can be 
assumed to remain intracellular36. To avoid growth-product couplings that are dependent on cytosolic proton 
balance, proton diffusion between the cytosol and extracellular medium was left unconstrained; indeed, the con-
dition-dependent protonation states of metabolites and the effect on their transport across the cell membrane are 
not well known. The sterol biosynthesis pathway from lanosterol to zymosterol was revised to match the co-factor 
requirements as per the latest yeast genome-scale metabolic model (ref. 37 Yeast v. 7.6, yeast.sourceforge.net). 
Additionally, only the mitochondrial version of the L-alanine aminotransferase was considered38. Finally, the 
model was preprocessed to remove blocked reactions – reactions that cannot carry flux under minimal medium 
with glucose as the sole carbon source. The reduced model was then augmented with the required heterologous 
pathways to generate the corresponding 28 producer models.
In silico metabolic engineering. To identify metabolic engineering targets, we used three distinct 
approaches: i) flux balance analysis (FBA)-based39 growth-product coupling; ii) MiMBl-based27 growth-product 
coupling and iii) flux variability analysis (FVA)40,41. The FBA-based approach was implemented as a variant of the 
OptKnock22 and RobustKnock42 algorithms. In brief, we calculated, for each of the simulated mutants, the mini-
mal product secretion while constraining the growth to its maximum possible limit. To identify growth-product 
couplings using FBA, we simulated all combinations of single, double and triple reaction knockouts. Additionally, 
combinations of three reaction knockouts were simulated on the top of two pre-selected sets of manually chosen 
deletions. The two pre-selected sets were: i) SDH3, SER3, and SER33 deletions, which have been shown to couple 
the glycine-serine pathway with growth25; and ii) ICL1, KGD1, and PYC1 deletions, which we expected to reroute 
the flux around the TCA cycle, favoring the heterologous synthesis of apigenin, chrysin, and luteolin. From the 
obtained solutions, we selected those with nonzero growth yield (≥ 10−2 g biomass/mol glucose) and product 
yield above 90% of the maximum yield among all solutions. Solutions with product yield lower than 10−3 mol/
mol glucose were not considered.
In the second approach, we used the MiMBl algorithm28 to predict the product flux for reaction knockout 
mutants. The use of the MiMBl algorithm requires a reference flux distribution (the “wild-type phenotype”) to 
calculate the metabolite turnover distance against. Since high-glucose conditions would be preferred for produc-
tion, we generated a reference flux distribution representing a carbon catabolite repressed (CCR) metabolic state. 
For this, a parsimonious FBA (pFBA)43 simulation was performed using the following additional constraints: i) 
no respiration, and ii) the directionality of the glucose 6-phosphate isomerase reaction restricted towards the 
formation of fructose 6-phosphate. As the MiMBl algorithm has not yet been validated beyond double gene dele-
tions, we restricted this approach to simulating single and double knockouts. The solutions were filtered to select 
those with growth yield ≥ 10−3 g biomass/mol glucose and product yield as in the case of FBA-based solutions.
Finally, reactions essential for the conversion of glucose into a particular product (at its maximum yield), and 
the minimal required flux through these, were identified using flux variability analysis40,41. The reactions thus 
identified constitute potential targets for gene overexpression.
All simulations were performed for minimal medium with glucose as the sole carbon source. To enumerate 
growth-product coupling solutions with the FBA and MiMBl algorithms, the IBM ILOG CPLEX v. 12.6.1 solver 
was accessed via C+ + API. Flux variability analysis was performed in Matlab R2015a v. 8.5.0 using IBM ILOG 
CPLEX v. 12.6.1 function ‘cplexlp’. All further calculations to filter the growth-product coupling solutions and to 
identify the essential reactions from the flux variability data were done with Matlab R2015a v. 8.5.0.
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Cluster analysis. Heatmaps were generated using R v. 3.2.044, with the function ‘heatmap.2’45. The clustering 
function used was ‘hclust’ with an average linkage method. The distance metrics ‘binary’ and ‘euclidean’ (accessed 
via function ‘dist’) were used for the product-essential flux data and stoichiometric precursor requirement data, 
respectively.
Figure 1. (A) The set of 29 heterologous and endogenous products considered in this study, overlaid on the 
native metabolic pathways of S. cerevisiae. Only the central metabolic pathways and metabolites relevant for 
these products are shown. The compounds are grouped according to their industrial use: drug precursors, flavor 
or aroma compounds, biofuels, and biopolymer precursors. (B) The heterologous pathways consume (black) 
and produce (red) compounds of the native metabolism. These pathways draw precursors as well as energy 
and redox cofactors from the native metabolism, in which the byproducts re-enter. Shown is the clustering of 
products according to these interactions with the yeast native metabolism.
www.nature.com/scientificreports/
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Results
All 29 products considered here originate from only a handful of precursors in the endogenous metabolism of S. 
cerevisiae (Fig. 1A). Due to the requirements for cofactors and/or secondary precursors, the relationships between 
different products go beyond the sharing of primary precursors. Furthermore, the host cells need to either metab-
olize, or secrete, the byproducts of these heterologous pathways. Indeed, we observed product clusters (Fig. 1B) 
that are based on all three factors – main precursor, co-factor usage, and by-product formation. These clusters 
affirm the notion of modularity and set the stage for exploring chassis designs.
Metabolic engineering targets for growth-product coupling. We identified reaction deletion strat-
egies that could couple the product flux to cell growth by applying an FBA-based approach to yeast metabolic 
models producing the 29 products considered here (see Methods). For all products, triple deletion strategies 
predicted higher product yields compared to single and double deletions (see Supplementary information). In the 
case of lactate production, some of the double deletion solutions were also considered among the potential strain 
designs as the corresponding predicted yields were above the set threshold (see Methods). We could identify 
growth-product coupling designs fulfilling our criteria for growth and product yields for 12 out of the 29 products 
(Fig. 2A). With the exception of products originating from the ergosterol or terpenoid pathway, growth-product 
coupling could be found for a broad range of products spanning precursors distributed throughout the native 
metabolic network of S. cerevisiae.
The potential for modular chassis designs is apparent in the solutions. In particular, we observed two major 
hub-deletions that are shared by several products: Δ pyc1,2 (pyruvate carboxylase) and Δ sdh3 (succinate dehy-
drogenase) (Fig. 2A). There are two pyruvate carboxylase isoenzymes (encoded by PYC1, PYC2) in S. cerevisiae. 
The mutant lacking both of the corresponding genes has been found to be inviable46, although the model predicts 
growth (i.e. putative false positive prediction). The strategy may still be implemented by deleting only one of the 
two genes or by down-regulating their expression. Knockout of the other predicted hub, succinate dehydrogenase 
(i.e. Sdh3_1, Sdh3_2), has been shown to disrupt the cyclic operation of the TCA cycle without affecting strain 
viability25.
TCA cycle disruption forms a basis for multiple growth-product couplings. An example non-intuitive 
chassis design involves pyruvate carboxylase inhibition combined with the disruption of the TCA cycle at the 
succinate dehydrogenase (Sdh3_1 & Sdh3_2) reactions and fumarase (encoded by FUM1) nodes (Fig. 2A). In this 
mutant, the malate synthase from the glyoxylate cycle is the only remaining source of malate necessary for oxalo-
acetate synthesis. Malate synthase uses acetyl-CoA and glyoxylate as substrates. The latter is available, at opti-
mal growth, only via the serine hydroxymethyl transferase (SHMT) route. This route produces glyoxylate from 
L-serine through glycine and glyoxylate aminotransferase (encoded by AGX1), while simultaneously converting 
homocysteine to L-methionine. The L-methionine derived SAM then couples SAM-consuming homoeriodictyol 
and vanillin production to growth (Fig. 2C).
In the growth-product coupling design for poly-beta-hydroxybutyrate production, the TCA cycle disrup-
tion at succinate dehydrogenase is instead combined with the blocking of the glycolytic L-serine synthesis. This 
renders the serine hydroxymethyl transferase (SHMT) route from glycine essential for L-serine synthesis. When 
glycine cannot be produced from L-serine, it can originate either from L-threonine aldolase, L-threonine dehy-
drogenase, or from transamination of glyoxylate. The growth-product coupling of poly-beta-hydroxybutyrate 
relies on L-threonine aldolase as a glycine source essential for optimal growth. This reaction produces acetalde-
hyde as a byproduct, which as a toxic metabolic intermediate, is readily converted to acetate and subsequently 
to acetyl-CoA. With further deletions of an acetate transporter (encoded by ADY2, in the model incorrectly 
annotated to BPH1), the carnitine shuttle of acetyl-CoA transport between compartments (e.g. Yat1), and the 
non-mitochondrial citrate synthase (i.e. Cit2), poly-beta-hydroxybutyrate production becomes coupled with 
optimal growth (Fig. 2). Assuming no mitochondrial acetyl-CoA synthetase activity (or additional disruption of 
any) when acetyl-CoA cannot enter the TCA cycle, poly-beta-hydroxybutyrate acts as a growth optimal sink for 
the overflow of acetyl-CoA.
The heterologous pathway for the synthesis of apigenin, chrysin, and luteolin includes a flavone synthase reac-
tion utilizing alpha-ketoglutarate and succinate as a redox pair. Thus, a combination of a disruption of the TCA 
cycle at the alpha-ketoglutarate dehydrogenase node (Δ kgd1), of the glyoxylate cycle at the isocitrate lyase node 
(Δ icl1), and the inhibition of pyruvate carboxylase together offered a suitable background network for searching 
additional gene deletion strategies. In this background, we searched for strategies to couple the flavone synthase 
to growth. Indeed, a suitable design was identified which required blocking the conversion through succinate 
semialdehyde dehydrogenase (Δ uga2) in combination with the deletions of acetate transporter (Δ ady2) and 
transketolase (Δ tkl2) (Fig. 2A).
p-hydroxycinnamic acid production forced by an imbalance in pentose phosphate pathway. 
p-hydroxycinnamic acid is synthesized from the aromatic amino acid L-tyrosine (Fig. 1). In the absence of aro-
matic amino acids in the growth medium, S. cerevisiae synthesizes these from the common precursors phos-
phoenolpyruvate and erythrose-4-phosphate. When the oxidative branch of the pentose phosphate pathway is 
blocked (i.e. Δ zwf1/sol1,2,3,4/gnd1,2) (Fig. 2A), transketolase provides growth essential pentose phosphates 
and erythrose-4-phosphate that are produced in one-to-one stoichiometry. However, this stoichiometry is not 
growth optimal but creates an overflow of erythrose-4-phosphate, which cannot be recycled in the absence of 
transaldolase activity (encoded by TAL1). When additionally L-tyrosine secretion is blocked (e.g. by deleting the 
corresponding transporter encoded by TAT1), p-hydroxycinnamic acid provides a growth optimal sink for the 
overflow of erythrose-4-phosphate.
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Production flux as an optimal route for recycling redox co-factors. In addition to the designs dis-
cussed above, which are based on carbon balancing, we observed a set of chassis designs that force a production 
pathway to be an optimal route for recycling redox co-factors. These designs (Fig. 2A) cover three products, 
lactate, butanol, and succinate. If respiration is blocked (e.g. Δ cox1) and pyruvate decarboxylase (encoded by 
PDC1/5/6) is inhibited, heterologous lactate dehydrogenase provides a growth-optimal NADH sink. Butanol 
synthesis is also NADH-consuming, making it a potential redox sink. When pyruvate carboxylase is inhibited and 
an increased NADH burden is created by rendering L-glutamate synthesis solely NADPH-dependent (i.e. Δ glt1), 
butanol synthesis becomes, under non-respiratory conditions (e.g. Δ rip1), a growth-optimal NADH sink.
Another example of coupling through redox balancing is the production of succinate – an intermediate 
metabolite of the TCA cycle. While a disruption of the TCA cycle at succinate dehydrogenase (encoded by SDH3) 
blocks the utilization of succinate, the inhibition of pyruvate decarboxylase (i.e. Δ pdc1) necessitates L-threonine 
aldolase to provide acetaldehyde to fulfill the requirement of cytosolic acetyl-CoA. The increased demand of flux 
through the L-threonine synthesis increases also the overall demand for NADPH for growth. This increase is due 
Figure 2. Examples of modularized growth-product coupling strain designs for S. cerevisiae identified with 
(A) the FBA-based algorithm (Methods), and (B) the MiMBl-based algorithm (Methods). These designs 
consist of reaction deletion targets, which are represented here in terms of the corresponding genes. In the 
case of isoenzymes, a representative gene, encoding the most active isoenzyme, is shown. (C) Illustration of 
how the production of vanillin becomes coupled to optimal growth through an L-methionine-Homocysteine 
interconversion in a deletion mutant where malate synthase and malate dehydrogenase reactions form an 
essential route to oxaloacetate.
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to the NADPH-requiring aspartic beta-semialdehyde dehydrogenase. Additionally, blocking the flux through 
the oxidative branch of the pentose phosphate pathway (i.e. Δ zwf1/sol1,2,3,4/gnd1,2), the main source of cyto-
solic NADPH, puts the alternative NADPH sources under pressure to increase flux. While isocitrate dehydroge-
nase (i.e. the isoenzyme encoded by IDP2) provides NADPH, succinate semialdehyde dehydrogenase (i.e. in the 
GABA shunt bypass of the TCA cycle) also produces NADPH and succinate. Succinate production thus becomes 
coupled to optimal growth as an optimal route for NADPH formation.
Disruption of glycolysis for growth coupling of glycerol pathway products. Propane-1,2-diol 
originates from dihydroxyacetone phosphate and propane-1,3-diol from glycerol (Fig. 1). A suggested strategy 
for the growth coupling of these products is to knock out the glycerol transporter (i.e. Δ fps1) while disrupting 
glycolysis at the glyceraldehyde 3-phosphate dehydrogenase (encoded by TDH1/2/3) and the fructose bisphos-
phate aldolase (encoded by FBA1) nodes (Fig. 2A). In this network disrupted in glycolysis, de novo NAD synthesis 
through kynurenine pathway and L-tryptophan synthesis would act as the sources of essential pyruvate, main-
taining cell viability. The deletions would also result in flux reorganization where, for optimal growth, glyceral-
dehyde 3-phosphate from the pentose phosphate pathway would be directed to dihydroxyacetone phosphate and 
further to the two products.
Metabolic engineering targets for regulatory growth-product coupling. The chassis designs dis-
cussed above assume growth optimality of the engineered strains. This would require, in most cases, a long-term 
adaptive evolution leading to an extensive rewiring of the regulatory networks. As an alternative approach, we used 
the MiMBl algorithm28, which predicts the fluxes in engineered strains without assuming growth optimality, but 
assumes minimal changes to the flux regulation in the reference strain (see Methods). In the strain designs identified 
using MiMBl, the endogenous flux regulation is expected to force flux through the production pathway so as to 
minimize the changes in metabolite turnovers in comparison to the wild type strain. In this study, as a reference flux 
distribution we considered glucose-repressed growth without oxidative phosphorylation. We identified such regula-
tory growth-product coupling strategies for 9 products (Fig. 2B), including 6-methylsalicylate for which no solutions 
were identified using the FBA-based algorithm. Interestingly, many deletion targets, including pyruvate carboxylase 
and pyruvate decarboxylase, overlap with the FBA-based designs, marking these as attractive engineering strategies.
Gene overexpression design strategies. The growth-product coupling strategies described above did 
not cover all of the 29 products. Moreover, the yields in such designs are inherently limited due to stringent 
growth requirements built in to the designs. This limitation could potentially be overcome by increasing the 
number of deletions, which may become impractical from an experimental perspective. Furthermore, increased 
deletions may not necessarily provide high yield solutions for all products24. In contrast, algorithms based on 
flux overexpression have been shown to suggest potentially high yield strategies in most cases29. We used flux 
variability analysis (FVA) to identify flux overexpression targets and the corresponding modular chassis designs 
spanning many products.
For each product, we identified reactions essential for obtaining optimal yield from glucose and also recorded 
the minimal required fluxes through these. Different product groups share many essential reactions among them, 
forming the basis for modular chassis designs (Fig. 3A,B). The required flux through these reactions, however, 
might differ from product to product. From an experimental implementation perspective, this could be tackled 
by using a library of promoters with different relative activities. The identified designs provide a blueprint for gene 
overexpression strategies that can be applied to multiple products.
Discussion
In this study, we provide modularized chassis designs for producing 29 different compounds of industrial interest 
in the widely used cell factory S. cerevisiae. The designs consist of both gene deletion targets for growth-product 
coupling as well as gene overexpression targets for boosting product yield. The growth-coupling algorithms 
used in this study have already been used to improve production of succinate, vanillin, and sesquiterpenes25,26. 
The vanillin- and isoprenoid-producing strains share a common strategy of generating NADPH surplus to be 
re-routed to the product pathway. Indeed, this shared basis of production improvement is consistent with the 
here-proposed concept of modular chassis design.
In addition to the specific targets for metabolic engineering, the designs identified here provide general 
insights into the flux re-routing associated with heterologous production. Our results highlight growth coupling as 
a fundamental strategy that can be applied to diverse products. Growth-product coupling arises when the product 
flux becomes either an unavoidable or an optimal byproduct of growth. In the case of an unavoidable byproduct, 
the optimal growth route includes a cleavage reaction generating an essential precursor for growth and a precur-
sor for the product. In the optimal-byproduct case, production becomes an optimal route for redox/cofactor bal-
ance. The mechanisms underlying such dependencies between growth and product flux are sensitive to the overall 
stoichiometry of the product formation and are not necessarily dictated by the main precursor. Consequently, 
many products grouped according to the shared targets in a non-intuitive fashion. This non-intuitive clustering 
is also observed in the case of MiMBl-based regulatory growth-product coupling as well as in the case of overex-
pression targets (based on flux variability analysis). Together, the chassis design strategies underline the need and 
usefulness of a comprehensive simulation approach as presented here. The proposed chassis designs at present do 
not directly consider kinetic or regulatory constraints on flux distributions. Experimentally measured metabolic 
phenotypes of a subset of the suggested mutant strains could provide a basis for further refinement of the chassis 
designs, possibly including modifications of signaling and regulatory pathways.
The modularized chassis designs proposed here offer an excellent starting point for experimental validation. 
The proposed deletion strains can be engineered using the broad gene disruption toolbox available for yeast, 
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including tools for simultaneous introduction of multiple gene deletions48–50. On the pathway front, new tools 
enable large pathways to be assembled and integrated in a high-throughput fashion51–53. These can also be used 
to integrate large pathways as bio-bricks into different strains. Thus, the bottleneck of metabolic engineering is 
shifting from pathway assembly to the optimization of the host metabolism. Given the large size of the native 
metabolism, the space of possible network modifications is extremely large and infeasible to explore in an exhaus-
tive manner. Thus, the chassis designs and methods proposed here offer an excellent starting point to tackle this 
challenge towards developing industrially attractive cell factories. In particular, the modular design enable using 
a pre-optimized strain for a family of products, and thus reducing the strain development time.
Figure 3. Modular chassis designs based on the shared product-essential reactions (overexpression targets) 
for optimal conversion of glucose into the selected products. (A) Clustering of product-essential reactions 
based on their utilization across different products. Only the reactions shared by sub-groups of products are 
shown while e.g. glucose transport and phosphorylation reactions shared by all are not included in the figure. 
The main origins of the products in the native metabolism are shown with color codes. (B) An example modular 
chassis design shown as a flow chart of module utilization by the products highlighted in the heatmap in (A).
www.nature.com/scientificreports/
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